MENU
CTMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CytomX Therapeutics (CTMX) Ownership - Who owns CytomX Therapeutics?

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
336.42M
P/E Ratio
4.08
Total Cash
158.09M
Projected Growth
N/A
Total Debt
6.89M
Revenue
141.1M
Risk (Beta)
3.73
Dividend Yield
N/A
Total Cash/Share
0.96
Total Debt/Equity
N/A
Revenue/Share
1.45 USD as % of share price

Fundamentals

CTMX
Capitalization
336M
P/E Ratio
4.08
Risk (Beta)
3.73
Dividend Yield
N/A
Total Cash
158M
Total Cash/Share
0.96
Total Debt
6.89M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.45%
Revenue
141M
ROE
N/A
Book Value
120M
P/B Ratio
2.81
Cash Flow
N/A
Earnings
0.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
4.20
Current Revenue Per Employee
154198.34
Dividends Per Share - Security
N/A
EBITDA
44.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
28.71
Shares Held By Institutions
143M
Shares Outstanding - Current
165M
Total Liabilities
55.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
98.058
View a ticker or compare two or three
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTMX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com